Late paradoxical development of pyoderma gangrenosum in a psoriasis patient treated with infliximab

Eur J Dermatol. May-Jun 2015;25(3):272-3. doi: 10.1684/ejd.2015.2526.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Dermatologic Agents / adverse effects*
  • Humans
  • Infliximab / adverse effects*
  • Male
  • Psoriasis / drug therapy*
  • Pyoderma Gangrenosum / chemically induced*
  • Time Factors
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Dermatologic Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab